DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) CEO Allan C. Thygesen sold 7,764 shares of the stock in a transaction that occurred on Friday, November 1st. The shares were sold at an average price of $69.95, for a total transaction of $543,091.80. Following the completion of the transaction, the chief executive officer now directly owns 107,825 shares of the company's stock, valued at approximately $7,542,358.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
DocuSign Stock Performance
Shares of NASDAQ DOCU traded down $1.26 during midday trading on Monday, hitting $69.85. 1,953,314 shares of the stock traded hands, compared to its average volume of 2,904,002. DocuSign, Inc. has a one year low of $39.65 and a one year high of $73.80. The business has a 50 day moving average price of $63.38 and a two-hundred day moving average price of $58.13. The company has a market cap of $14.18 billion, a PE ratio of 14.74, a P/E/G ratio of 7.34 and a beta of 0.90.
DocuSign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.17. The firm had revenue of $736.03 million for the quarter, compared to the consensus estimate of $727.20 million. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The business's revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.09 earnings per share. As a group, equities research analysts forecast that DocuSign, Inc. will post 1.01 EPS for the current fiscal year.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the stock. Massmutual Trust Co. FSB ADV lifted its holdings in DocuSign by 5,000.0% during the second quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company's stock worth $27,000 after acquiring an additional 500 shares during the period. Mather Group LLC. increased its position in shares of DocuSign by 4,338.5% during the 2nd quarter. Mather Group LLC. now owns 577 shares of the company's stock valued at $31,000 after purchasing an additional 564 shares during the last quarter. Reston Wealth Management LLC bought a new stake in shares of DocuSign during the 3rd quarter worth $47,000. nVerses Capital LLC purchased a new position in shares of DocuSign in the 2nd quarter worth about $48,000. Finally, Quarry LP bought a new position in DocuSign during the second quarter valued at about $53,000. Institutional investors own 77.64% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on DOCU. Wells Fargo & Company boosted their price objective on shares of DocuSign from $48.00 to $50.00 and gave the stock an "underweight" rating in a research note on Friday, September 6th. Citigroup raised their price objective on DocuSign from $86.00 to $87.00 and gave the stock a "buy" rating in a research report on Friday, September 6th. Needham & Company LLC reiterated a "hold" rating on shares of DocuSign in a report on Friday, September 6th. Royal Bank of Canada raised their price target on shares of DocuSign from $52.00 to $57.00 and gave the stock a "sector perform" rating in a report on Friday, September 6th. Finally, Bank of America boosted their price target on shares of DocuSign from $60.00 to $68.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $63.40.
View Our Latest Research Report on DOCU
About DocuSign
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.